Reaching your goals sooner
Vaccine trials present an array of challenges, including recruiting special populations, collecting complex lab data and entering new geographies—often under tight timelines. How do you minimize start-up time and study duration, collect the right mix of data and connect with the right patients in the right places?
We share a common goal: decreasing the burden of infectious disease on human health. Quintiles offers the experience, capabilities and global reach—combined with an unmatched strategy for start-up performance—to optimize your vaccine development process. Quintiles has:
- Provided clinical services for more than 130 vaccine studies involving 300,000+ subjects and nearly 3,000 investigator sites in 59 countries.
- Helped develop or commercialize 94% (47 of 50) of 2013’s top 50 best-selling vaccine products or compounds and 100% of the top 35.
- Helped develop or commercialize 93% (14 of 15) of 2013’s top 15 best-selling Hepatitis C products or compounds.
- Helped develop or commercialize 91% (32 of 35) of 2013’s top 35 best-selling HIV products or compounds.
Comprehensive lab capabilities
Quintiles has CAP-accredited, regionally located central labs, including a tuberculosis lab in South Africa, that are all connected through our Infosario™ Investigator Site Portal. We offer a range of laboratory services, including immunoassays and biomarker identification.
Our vast global footprint allows us to help you quickly scale up or down and readily connect with appropriate patients using our local presence. With more than 33,000 employees worldwide, and people on the ground in all major regions, including South Africa, Latin America and Asia Pacific, we provide vital insight into regional regulations and cultural sensitivities.
Clinical and commercialization expertise
Quintiles’ Vaccine Center of Excellence comprises nearly 500 experienced vaccine team members who are ready to execute your clinical study with high-quality results. Our innovative delivery models boost portfolio productivity and differentiation, rapid startup, shorter enrollment and study timelines. Our expertise spans across the product lifecycle, from pre-clinical testing, through market access and commercialization strategies.
Experience and scientific edge can help you make a difference in vaccine development.